Logo image of IB.CA

IBC ADVANCED ALLOYS CORP (IB.CA) Stock Fundamental Analysis

TSX-V:IB - TSX Venture Exchange - CA44923T8683 - Common Stock - Currency: CAD

0.07  0 (-6.67%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to IB. IB was compared to 802 industry peers in the Metals & Mining industry. There are concerns on the financial health of IB while its profitability can be described as average. IB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

IB had negative earnings in the past year.
IB had a positive operating cash flow in the past year.
In the past 5 years IB reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: IB reported negative operating cash flow in multiple years.
IB.CA Yearly Net Income VS EBIT VS OCF VS FCFIB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

With a decent Return On Assets value of -4.40%, IB is doing good in the industry, outperforming 73.69% of the companies in the same industry.
With a Return On Equity value of -31.29%, IB perfoms like the industry average, outperforming 49.88% of the companies in the same industry.
The Return On Invested Capital of IB (8.19%) is better than 94.26% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IB is significantly below the industry average of 24.51%.
Industry RankSector Rank
ROA -4.4%
ROE -31.29%
ROIC 8.19%
ROA(3y)-6.04%
ROA(5y)-6%
ROE(3y)-61.56%
ROE(5y)-45.38%
ROIC(3y)8.59%
ROIC(5y)N/A
IB.CA Yearly ROA, ROE, ROICIB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

IB's Operating Margin of 4.29% is amongst the best of the industry. IB outperforms 89.15% of its industry peers.
IB's Gross Margin of 22.43% is amongst the best of the industry. IB outperforms 89.15% of its industry peers.
In the last couple of years the Gross Margin of IB has grown nicely.
Industry RankSector Rank
OM 4.29%
PM (TTM) N/A
GM 22.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.81%
GM growth 5Y37.22%
IB.CA Yearly Profit, Operating, Gross MarginsIB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IB is destroying value.
The number of shares outstanding for IB has been increased compared to 1 year ago.
The number of shares outstanding for IB has been increased compared to 5 years ago.
IB has a worse debt/assets ratio than last year.
IB.CA Yearly Shares OutstandingIB.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
IB.CA Yearly Total Debt VS Total AssetsIB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

IB has an Altman-Z score of -2.22. This is a bad value and indicates that IB is not financially healthy and even has some risk of bankruptcy.
IB's Altman-Z score of -2.22 is on the low side compared to the rest of the industry. IB is outperformed by 60.60% of its industry peers.
The Debt to FCF ratio of IB is 3.99, which is a good value as it means it would take IB, 3.99 years of fcf income to pay off all of its debts.
IB has a better Debt to FCF ratio (3.99) than 92.39% of its industry peers.
IB has a Debt/Equity ratio of 3.43. This is a high value indicating a heavy dependency on external financing.
IB has a Debt to Equity ratio of 3.43. This is in the lower half of the industry: IB underperforms 76.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.43
Debt/FCF 3.99
Altman-Z -2.22
ROIC/WACC0.54
WACC15.23%
IB.CA Yearly LT Debt VS Equity VS FCFIB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

IB has a Current Ratio of 0.78. This is a bad value and indicates that IB is not financially healthy enough and could expect problems in meeting its short term obligations.
IB has a worse Current ratio (0.78) than 62.22% of its industry peers.
IB has a Quick Ratio of 0.78. This is a bad value and indicates that IB is not financially healthy enough and could expect problems in meeting its short term obligations.
IB's Quick ratio of 0.20 is on the low side compared to the rest of the industry. IB is outperformed by 75.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.2
IB.CA Yearly Current Assets VS Current LiabilitesIB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

1

3. Growth

3.1 Past

IB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.73%, which is quite impressive.
IB shows a small growth in Revenue. In the last year, the Revenue has grown by 7.17%.
IB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.57% yearly.
EPS 1Y (TTM)59.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)7.17%
Revenue growth 3Y5.58%
Revenue growth 5Y6.57%
Sales Q2Q%-64.58%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IB.CA Yearly Revenue VS EstimatesIB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IB.CA Price Earnings VS Forward Price EarningsIB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IB is valued cheaper than 93.89% of the companies in the same industry.
IB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IB is cheaper than 99.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.05
EV/EBITDA 6.55
IB.CA Per share dataIB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for IB!.
Industry RankSector Rank
Dividend Yield N/A

IBC ADVANCED ALLOYS CORP

TSX-V:IB (5/8/2025, 7:00:00 PM)

0.07

0 (-6.67%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-03 2025-03-03/bmo
Earnings (Next)05-14 2025-05-14
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners26.39%
Ins Owner ChangeN/A
Market Cap7.94M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF 2.05
P/OCF 1.73
P/B 1.97
P/tB 1.97
EV/EBITDA 6.55
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.03
FCFY48.78%
OCF(TTM)0.04
OCFY57.65%
SpS0.42
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.4%
ROE -31.29%
ROCE 19.73%
ROIC 8.19%
ROICexc 8.39%
ROICexgc 8.39%
OM 4.29%
PM (TTM) N/A
GM 22.43%
FCFM 8.17%
ROA(3y)-6.04%
ROA(5y)-6%
ROE(3y)-61.56%
ROE(5y)-45.38%
ROIC(3y)8.59%
ROIC(5y)N/A
ROICexc(3y)8.94%
ROICexc(5y)N/A
ROICexgc(3y)8.94%
ROICexgc(5y)N/A
ROCE(3y)22.06%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.81%
GM growth 5Y37.22%
F-Score6
Asset Turnover1.65
Health
Industry RankSector Rank
Debt/Equity 3.43
Debt/FCF 3.99
Debt/EBITDA 5.89
Cap/Depr 220.44%
Cap/Sales 1.49%
Interest Coverage 0.65
Cash Conversion 194.51%
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.2
Altman-Z -2.22
F-Score6
WACC15.23%
ROIC/WACC0.54
Cap/Depr(3y)123.98%
Cap/Depr(5y)119.16%
Cap/Sales(3y)6.42%
Cap/Sales(5y)6.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.17%
Revenue growth 3Y5.58%
Revenue growth 5Y6.57%
Sales Q2Q%-64.58%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y236.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y172.38%
FCF growth 3Y91.32%
FCF growth 5YN/A
OCF growth 1Y231.12%
OCF growth 3Y16.46%
OCF growth 5YN/A